These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12847059)

  • 1. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.
    Hodis HN; Mack WJ; Lobo RA
    Circulation; 2003 Jul; 108(1):e5; author reply e5. PubMed ID: 12847059
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone replacement therapy and prevention: no chance for celebration? What should doctors do? A personal opinion.
    Rossi R; Modena MG
    Ital Heart J; 2002 Dec; 3(12):693-8. PubMed ID: 12611118
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
    Stehouwer CD
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):61-4. PubMed ID: 11225257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement does not prevent recurrent stroke or death in postmenopausal women after an ischemic stroke.
    Basile JN
    J Clin Hypertens (Greenwich); 2002; 4(1):48-9. PubMed ID: 11821638
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRT as secondary prevention of cardiovascular disease.
    Ylikorkala O
    Maturitas; 2004 Apr; 47(4):315-8. PubMed ID: 15063485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk and hormone replacement therapy.
    Lawlor DA; Smith GD
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):658-65. PubMed ID: 17099339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E
    Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal estrogen and cardiovascular disease.
    Stampfer MJ; Grodstein F; Bechtel S
    Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970
    [No Abstract]   [Full Text] [Related]  

  • 20. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.